359 related articles for article (PubMed ID: 29397780)
1. Depressive symptoms affect outcomes of pessary use in postmenopausal women with uterine prolapse.
Ai FF; Zhu L; Mao M; Zhang Y; Kang J
Climacteric; 2018 Apr; 21(2):184-188. PubMed ID: 29397780
[TBL] [Abstract][Full Text] [Related]
2. Depressive symptoms screening in postmenopausal women with symptomatic pelvic organ prolapse.
Ai F; Deng M; Mao M; Xu T; Zhu L
Menopause; 2018 Mar; 25(3):314-319. PubMed ID: 29040216
[TBL] [Abstract][Full Text] [Related]
3. Effect of generalized anxiety disorders on the success of pessary treatment for pelvic organ prolapse.
Ai FF; Mao M; Zhang Y; Kang J; Zhu L
Int Urogynecol J; 2018 Aug; 29(8):1147-1153. PubMed ID: 29478112
[TBL] [Abstract][Full Text] [Related]
4. Responsiveness of the Pelvic Floor Distress Inventory (PFDI) and Pelvic Floor Impact Questionnaire (PFIQ) in women undergoing vaginal surgery and pessary treatment for pelvic organ prolapse.
Barber MD; Walters MD; Cundiff GW;
Am J Obstet Gynecol; 2006 May; 194(5):1492-8. PubMed ID: 16647933
[TBL] [Abstract][Full Text] [Related]
5. Screening for general anxiety disorders in postmenopausal women with symptomatic pelvic organ prolapse.
Ai F; Deng M; Mao M; Xu T; Zhu L
Climacteric; 2018 Feb; 21(1):35-39. PubMed ID: 29095064
[TBL] [Abstract][Full Text] [Related]
6. Psychometric evaluation of 2 comprehensive condition-specific quality of life instruments for women with pelvic floor disorders.
Barber MD; Kuchibhatla MN; Pieper CF; Bump RC
Am J Obstet Gynecol; 2001 Dec; 185(6):1388-95. PubMed ID: 11744914
[TBL] [Abstract][Full Text] [Related]
7. [Clinical study on silicone pessary in the treatment of pelvic organ prolapse].
Yang JF; Han JS; Zhu FL; Wang YT; Yao Y; Qiao J
Zhonghua Fu Chan Ke Za Zhi; 2012 Jul; 47(7):487-91. PubMed ID: 23141156
[TBL] [Abstract][Full Text] [Related]
8. Changes in the symptoms and quality of life of women with symptomatic pelvic organ prolapse fitted with a ring with support pessary.
Mao M; Ai F; Zhang Y; Kang J; Liang S; Xu T; Zhu L
Maturitas; 2018 Nov; 117():51-56. PubMed ID: 30314561
[TBL] [Abstract][Full Text] [Related]
9. Responsiveness of the Pelvic Floor Distress Inventory and Pelvic Floor Impact Questionnaire in women undergoing treatment for pelvic floor disorders.
Chan SS; Cheung RY; Lai BP; Lee LL; Choy KW; Chung TK
Int Urogynecol J; 2013 Feb; 24(2):213-21. PubMed ID: 22669425
[TBL] [Abstract][Full Text] [Related]
10. Successful long-term use of Gellhorn pessary and the effect on symptoms and quality of life in women with symptomatic pelvic organ prolapse.
Mao M; Ai F; Kang J; Zhang Y; Liang S; Zhou Y; Zhu L
Menopause; 2019 Feb; 26(2):145-151. PubMed ID: 30130292
[TBL] [Abstract][Full Text] [Related]
11. Vaginal Pessary in Women With Symptomatic Pelvic Organ Prolapse: A Randomized Controlled Trial.
Cheung RY; Lee JH; Lee LL; Chung TK; Chan SS
Obstet Gynecol; 2016 Jul; 128(1):73-80. PubMed ID: 27275798
[TBL] [Abstract][Full Text] [Related]
12. Responsiveness of the Spanish Pelvic Floor Distress Inventory and Pelvic Floor Impact Questionnaires Short Forms (PFDI-20 and PFIQ-7) in women with pelvic floor disorders.
Sánchez Sánchez B; Torres Lacomba M; Navarro Brazález B; Cerezo Téllez E; Pacheco Da Costa S; Gutiérrez Ortega C
Eur J Obstet Gynecol Reprod Biol; 2015 Jul; 190():20-5. PubMed ID: 25955564
[TBL] [Abstract][Full Text] [Related]
13. Quality of life in women who use pessaries for longer than 12 months.
Tenfelde S; Tell D; Thomas TN; Kenton K
Female Pelvic Med Reconstr Surg; 2015; 21(3):146-9. PubMed ID: 25521465
[TBL] [Abstract][Full Text] [Related]
14. Pelvic floor symptom changes in pessary users.
Komesu YM; Rogers RG; Rode MA; Craig EC; Gallegos KA; Montoya AR; Swartz CD
Am J Obstet Gynecol; 2007 Dec; 197(6):620.e1-6. PubMed ID: 18060953
[TBL] [Abstract][Full Text] [Related]
15. Impact of laparoscopic sacrocolpopexy on symptoms, health-related quality of life and sexuality: a medium-term analysis.
Thibault F; Costa P; Thanigasalam R; Seni G; Brouzyine M; Cayzergues L; De Tayrac R; Droupy S; Wagner L
BJU Int; 2013 Dec; 112(8):1143-9. PubMed ID: 24007194
[TBL] [Abstract][Full Text] [Related]
16. Association between pelvic floor disorder symptoms and QoL scores with depressive symptoms among pelvic organ prolapse patients.
Pizarro-Berdichevsky J; Hitschfeld MJ; Pattillo A; Blumel B; Gonzalez S; Arellano M; Cuevas R; Alvo J; Gorodischer A; Flores-Espinoza C; Goldman HB
Aust N Z J Obstet Gynaecol; 2016 Aug; 56(4):391-7. PubMed ID: 27135639
[TBL] [Abstract][Full Text] [Related]
17. Effect of pessary use on genital hiatus measurements in women with pelvic organ prolapse.
Jones K; Yang L; Lowder JL; Meyn L; Ellison R; Zyczynski HM; Moalli P; Lee T
Obstet Gynecol; 2008 Sep; 112(3):630-6. PubMed ID: 18757662
[TBL] [Abstract][Full Text] [Related]
18. Patient Satisfaction and Symptoms Improvement in Women Using a Vginal Pessary for The Treatment of Pelvic Organ Prolapse.
Radnia N; Hajhashemi M; Eftekhar T; Deldar M; Mohajeri T; Sohbati S; Ghanbari Z
J Med Life; 2019; 12(3):271-275. PubMed ID: 31666830
[TBL] [Abstract][Full Text] [Related]
19. Patient-reported goal attainment and comprehensive functioning outcomes after surgery compared with pessary for pelvic organ prolapse.
Sung VW; Wohlrab KJ; Madsen A; Raker C
Am J Obstet Gynecol; 2016 Nov; 215(5):659.e1-659.e7. PubMed ID: 27319365
[TBL] [Abstract][Full Text] [Related]
20. The impact of personality traits on pessary treatment outcomes in patients with pelvic organ prolapse.
Ma C; Kang J; Xu T; Zhang Y; Ma Y; Zhu L
Int Urogynecol J; 2021 Apr; 32(4):859-864. PubMed ID: 33206221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
